Tyrosine Kinase Inhibitors

Home/Tag: Tyrosine Kinase Inhibitors

Update on Potential Treatments for Imatinib-Resistant GIST

In a recent article entitled "Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions" published online in Springer for Research and Development,  LRG Research Team member Sebastian Bauer [...]

By |2019-10-31T12:01:30-04:00July 31st, 2015|News, Research|

Lancet Oncology Publishes List of Drugs to Avoid for Patients on Tyrosine Kinase Inhibitors

Lancet Oncology, a comprehensive overview of known or suspected drug-drug interactions between tyrosine-kinase inhibitors (Gleevec, Sutent, Stivarga) prescribed for GIST.

By |2019-09-20T14:49:25-04:00August 5th, 2014|Drug Treatment, News|
Go to Top